Speaking Engagements – Eascra Biotech

Our CEO Mari Anne Snow was a panelist at the Massachusetts Biomedical Initiative’s “Lunch and Learn” program, discussing “Overcoming Setbacks” in startups.

In this Startup Profile, our CEO Mari Anne Snow is interviewed by Brad Loncar and BiotechTV.

In March 2026 our CEO Mari Anne Snow was a panelist at Tech Connect’s Biotech in Space Symposium. The panel topic: Funding Opportunities for R&D in Microgravity; Discussing Public and Private Funding Mechanisms for Commercial Space Ventures.

In March 2026, our Life Science Research Scientist Dr. Ian Sands, Ph.D pitched (and won first place) in the Tech Connect’s Biotech in Space Symposium’s “Bio in Space Innovation Challenge” competition. Dr. Sands spoke on “Microgravity-Optimized Janus Base Nanoparticles” and how Eascra Biotech leverages space and microgravity to advance development and commercialization of biomaterials.

In December 2025, our Co-Founder & Science Advisor Dr. Yupeng Chen Ph.D presented at the American Society for Gravitational and Space Research convention. Dr. Chen presented on the topic “The Gravity of Growth: Automation, Biotech, and Capital in LEO and Beyond”.

In December 2025, our Life Science Research Scientist Dr. Ian Sands, Ph.D presented at the American Society for Gravitational and Space Research convention. Dr. Sands presented on the topic “Reversing the Impact of Microgravity on Engineered Cartilage Tissue in Space”.

In December 2025, Maddie Pickett M.Eng. presented at the American Society for Gravitational and Space Research convention. Maddie presented on the topic “Enabling Technologies – Biology and Life Science”.

In September 2025, our CEO Mari Anne Snow and our Co-Founder & Science Advisor Dr. Yupeng Chen Ph.D were interviewed on the official podcast of the International Space Station’s National Lab “Between a Rocket and a Hard Space” They discussed their collaborative efforts to develop nanomaterials in microgravity that could one day revolutionize treatments for diseases ranging from cancer to osteoarthritis.

In November 2025, our CEO Mari Anne Snow was interviewed on the program “Supplier Horizons”, where she spoke about Eascra Biotech’s work, and what we have been doing in space and on earth to advance medical treatments for patients in need.

In September 2025, our CEO Mari Anne Snow spoke at the Newport Investor Summit, sharing Eascra Biotech’s vision and what we have been doing in space and on earth to advance medical treatments for patients in need.

Our CEO Mari Anne Snow will be a guest speaker at The Future Space Economy webinar, speaking about our use of Low Earth orbit (LEO) for pharmaceutical development. To learn more about this and other exciting new developments in space medicine, join this free webinar on Monday, July 21, 2025 at 1:00 PM EDT. View recording here.

View Recording >>

Big News!

Eascra Biotech has been selected as a finalist for the Tech Connect’s Space Innovation Challenge. Our CEO Mari Anne Snow will be presenting at the event held at National Harbor, MD August 27th – 29th 2025.

Learn More >>